Stop-movement device for elongated medical assembly

Information

  • Patent Grant
  • 11938285
  • Patent Number
    11,938,285
  • Date Filed
    Monday, June 14, 2021
    2 years ago
  • Date Issued
    Tuesday, March 26, 2024
    a month ago
Abstract
A stop-movement device is configured to be mounted to a first elongated medical assembly and a second elongated medical assembly. The stop-movement device has a body configured to stop, at least in part, relative movement between the second elongated medical assembly and the first elongated medical assembly.
Description
TECHNICAL FIELD

This document relates to the technical fields of (A) an apparatus (for use with a first elongated medical assembly and a second elongated medical assembly) including a stop-movement device; and (B) an apparatus including a synergistic combination of a first elongated medical assembly, a second elongated medical assembly and a stop-movement device; and (C) a method of operating a stop-movement device with a first elongated medical assembly and a second elongated medical assembly; and (D) an apparatus (for use with an elongated dilator assembly and an elongated needle assembly) including a stop-movement device; and (E) an apparatus including a synergistic combination of an elongated dilator assembly, an elongated needle assembly and a stop-movement device; and (F) a method of operating a stop-movement device with an elongated dilator assembly and an elongated needle assembly.


BACKGROUND

Known medical devices are configured to facilitate a medical procedure, and help healthcare providers diagnose and/or treat medical conditions of sick patients.


SUMMARY

It will be appreciated that there exists a need to mitigate (at least in part) at least one problem associated with the existing (known) dilators and/or guidewires, etc., (also called the existing technology). After much study of, and experimentation with, the existing (known) dilators and/or guidewires, etc., an understanding (at least in part) of the problem and its solution have been identified (at least in part) and are articulated (at least in part) as follows:


Referring to the embodiment as depicted in FIG. 1 (known puncture device and the hub of the dilator), physicians may use a known technique (such as, the two-finger technique) wherein a finger is placed between a puncture device 800 (also called a needle), and a hub 801 of the dilator and the elongated sheath assembly 804. As depicted in FIG. 1, the handling of the puncture device 800 is performed by using the known two-finger technique (by a single hand 802). This technique may be awkward to execute (may waste valuable procedural time), and/or may lead to inadvertent injury to the patient and/or the surgeon, etc. For instance, when performing a transseptal puncture procedure, it may be necessary to maintain the puncture device 800 in place with respect to the hub 801 of the dilator and elongated sheath assembly 804. The puncture device 800 may have a hub 806 and may include a mechanical needle and/or a radio-frequency needle, etc. For example, when tenting the fossa ovalis (of the heart or any biological feature of the patient), the puncture device 800 may be positioned proximal to a tip of the elongated dilator assembly. If this is not the case, inadvertent (unwanted) puncture of the fossa ovalis and/or unwanted damage to other cardiac structures (biological features) may be possible.


What may be desired is an assembly configured to allow a user (a physician, etc.) to avoid usage of the known 2-finger technique. What may be desired is an assembly configured to allow the user to secure a puncture device during a procedure. What may be desired is an assembly configured to provide a better way to improve, at least in part, safety for a user using a procedure, such as a transseptal technique, etc.


To mitigate, at least in part, at least one problem associated with the existing technology, there is provided (in accordance with a major aspect) an apparatus. The apparatus is for (is configured to be utilized with) a first elongated medical assembly and a second elongated medical assembly configured to be receivable, at least in part, inside and movable, at least in part, along the first elongated medical assembly. The apparatus includes and is not limited to (comprises) a stop-movement device configured to be mounted to the first elongated medical assembly and the second elongated medical assembly. This is done, preferably, after the second elongated medical assembly, in use, is received, at least in part, inside the first elongated medical assembly. The stop-movement device has a body configured to stop, at least in part, relative movement between the second elongated medical assembly and the first elongated medical assembly. This is done, preferably, after the stop-movement device is mounted to the second elongated medical assembly and first elongated medical assembly.


To mitigate, at least in part, at least one problem associated with the existing technology, there is provided (in accordance with a major aspect) an apparatus. The apparatus is for (is configured to be utilized with) an elongated dilator assembly and an elongated needle assembly configured to be receivable, at least in part, inside and movable, at least in part, along the elongated dilator assembly. The apparatus includes and is not limited to a stop-movement device configured to be mounted to the elongated needle assembly and the elongated dilator assembly. This is done, preferably, after the elongated needle assembly, in use, is received, at least in part, inside the elongated dilator assembly. The stop-movement device has a body configured to stop, at least in part, relative movement between the elongated needle assembly and the elongated dilator assembly. This is done, preferably, after the stop-movement device is mounted to the elongated needle assembly and the elongated dilator assembly.


To mitigate, at least in part, at least one problem associated with the existing technology, there is provided (in accordance with a major aspect) an apparatus. The apparatus includes and is not limited to (comprises) a synergistic combination of an elongated dilator assembly, an elongated needle assembly and a stop-movement device. The elongated needle assembly is configured to be receivable, at least in part, inside and movable, at least in part, along the elongated dilator assembly. The stop-movement device is configured to be mounted to the elongated needle assembly and the elongated dilator assembly; this is done, preferably, after the elongated needle assembly, in use, is received, at least in part, inside the elongated dilator assembly. The stop-movement device has a body configured to stop, at least in part, relative movement between the elongated needle assembly and the elongated dilator assembly; this is done, preferably, after the stop-movement device is mounted to the elongated needle assembly and the elongated dilator assembly.


To mitigate, at least in part, at least one problem associated with the existing technology, there is provided (in accordance with a major aspect) a method. The method is for using the stop-movement device with an elongated dilator assembly and an elongated needle assembly configured to be receivable, at least in part, inside and movable, at least in part, along the elongated dilator assembly. The method includes and is not limited to (comprises) mounting the stop-movement device to the elongated needle assembly and the elongated dilator assembly; this is done, preferably, after the elongated needle assembly, in use, is received, at least in part, inside the elongated dilator assembly. The method also includes stopping relative movement between the elongated needle assembly and the elongated dilator assembly with a body of the stop-movement device; this is done, preferably, after the stop-movement device is mounted to the elongated needle assembly and the elongated dilator assembly.


Other aspects are identified in the claims. Other aspects and features of the non-limiting embodiments may now become apparent to those skilled in the art upon review of the following detailed description of the non-limiting embodiments with the accompanying drawings. This Summary is provided to introduce concepts in simplified form that are further described below in the Detailed Description. This Summary is not intended to identify potentially key features or possible essential features of the disclosed subject matter, and is not intended to describe each disclosed embodiment or every implementation of the disclosed subject matter. Many other novel advantages, features, and relationships will become apparent as this description proceeds. The figures and the description that follow more particularly exemplify illustrative embodiments.





BRIEF DESCRIPTION OF THE DRAWINGS

The non-limiting embodiments may be more fully appreciated by reference to the following detailed description of the non-limiting embodiments when taken in conjunction with the accompanying drawings, in which:



FIG. 1 depicts side view of a known puncture device and the hub of the dilator;



FIG. 2 depicts a side perspective view of an embodiment of a stop-movement device configured to be mounted to an elongated needle assembly and an elongated dilator assembly;



FIG. 3 depicts a close-up side perspective view of an embodiment of the stop-movement device of FIG. 2;



FIG. 4 to FIG. 10 depict side views (FIG. 4, FIG. 5, FIG. 6, FIG. 8 and FIG. 10) and perspective side views (FIG. 7 and FIG. 9) of embodiments of a method of utilizing the stop-movement device of FIG. 2; and



FIG. 11 to FIG. 14 depict end perspective views (FIG. 11 and FIG. 14), an end view (FIG. 12) and a side perspective view (FIG. 13) of embodiments of the stop-movement device of FIG. 2.





The drawings are not necessarily to scale and may be illustrated by phantom lines, diagrammatic representations, and fragmentary views. In certain instances, details unnecessary for an understanding of the embodiments (and/or details that render other details difficult to perceive) may have been omitted. Corresponding reference characters indicate corresponding components throughout the several figures of the drawings. Elements in the several figures are illustrated for simplicity and clarity and have not been drawn to scale. The dimensions of some of the elements in the figures may be emphasized relative to other elements for facilitating an understanding of the various disclosed embodiments. In addition, common, and well-understood, elements that are useful in commercially feasible embodiments are often not depicted to provide a less obstructed view of the embodiments of the present disclosure.












LISTING OF REFERENCE NUMERALS USED IN THE DRAWINGS
















elongated medical assembly 100
dilator hub portion 104


elongated dilator assembly 102
dilator tip 105


proximal end portion 103
end section 112


elongated medical assembly 200
single body member 380


elongated needle assembly 202
first end face 381


distal puncture device 204
second end face 382


handle 206
step 384


stop-movement device 300
first inner wall surface 391


body 301
second inner wall surface 392


receiving portal 302
guidewire assembly 401


first body 311
sheath assembly 402


second body 312
first interior zone 501


first body cavity 321
second interior zone 502


first body groove 322
first movement direction 601


second body cavity 331
second movement direction 602


second body groove 332
axial movement direction 603


first step 341
puncture device 800


second step 342
single hand 802


first entrance 351
elongated sheath assembly 804


second entrance 352
needle handle 806


first connection protrusion 361
energy generator 900


second connection protrusion 362
electrical connection 902


first connection groove 371
biological feature 904


second connection groove 372
puncture hole 905









DETAILED DESCRIPTION OF THE NON-LIMITING EMBODIMENT(S)

The following detailed description is merely exemplary and is not intended to limit the described embodiments or the application and uses of the described embodiments. As used, the word “exemplary” or “illustrative” means “serving as an example, instance, or illustration.” Any implementation described as “exemplary” or “illustrative” is not necessarily to be construed as preferred or advantageous over other implementations. All of the implementations described below are exemplary implementations provided to enable persons skilled in the art to make or use the embodiments of the disclosure and are not intended to limit the scope of the disclosure. The scope of the disclosure is defined by the claims. For the description, the terms “upper,” “lower,” “left,” “rear,” “right,” “front,” “vertical,” “horizontal,” and derivatives thereof shall relate to the examples as oriented in the drawings. There is no intention to be bound by any expressed or implied theory in the preceding Technical Field, Background, Summary or the following detailed description. It is also to be understood that the devices and processes illustrated in the attached drawings, and described in the following specification, are exemplary embodiments (examples), aspects and/or concepts defined in the appended claims. Hence, dimensions and other physical characteristics relating to the embodiments disclosed are not to be considered as limiting, unless the claims expressly state otherwise. It is understood that the phrase “at least one” is equivalent to “a”. The aspects (examples, alterations, modifications, options, variations, embodiments and any equivalent thereof) are described regarding the drawings. It should be understood that the disclosure is limited to the subject matter provided by the claims, and that the disclosure is not limited to the particular aspects depicted and described. It will be appreciated that the scope of the meaning of a device configured to be coupled to an item (that is, to be connected to, to interact with the item, etc.) is to be interpreted as the device being configured to be coupled to the item, either directly or indirectly. Therefore, “configured to” may include the meaning “either directly or indirectly” unless specifically stated otherwise.



FIG. 2 depicts a side perspective view of an embodiment of a stop-movement device 300 configured to be mounted to an elongated needle assembly 202 and an elongated dilator assembly 102.



FIG. 3 depicts a close-up side perspective view of an embodiment of the stop-movement device 300 of FIG. 2.


Referring to the embodiments as depicted in FIG. 2 and FIG. 3, it will be appreciated that a first elongated medical assembly 100, a second elongated medical assembly 200 and a stop-movement device 300 may be manufactured, or provided by, separately. For this case, there is provided an apparatus for (configured to be used with) the first elongated medical assembly 100 and the second elongated medical assembly 200 configured to be receivable, at least in part, inside and movable, at least in part, along the first elongated medical assembly 100. The apparatus includes, and is not limited to, a stop-movement device 300 configured to be mounted to the first elongated medical assembly 100 and the second elongated medical assembly 200; this is done, preferably, after the second elongated medical assembly 200, in use, is received, at least in part, inside the first elongated medical assembly 100. The stop-movement device 300 has a body 301 configured to stop, at least in part, relative movement between the second elongated medical assembly 200 and the first elongated medical assembly 100. This is done, preferably, after the stop-movement device 300 is mounted to the second elongated medical assembly 200 and first elongated medical assembly 100.


Referring to the embodiments as depicted in FIG. 2 and FIG. 3, the stop-movement device 300 includes, preferably, SAE (Society of Automotive Engineering) Type 304 Stainless Steel, and any equivalent thereof. SAE Type 304 stainless steel contains both chromium (from between about 15% to about 20%) and nickel (from between about 2% to about 10.5%) metals as the main non-iron constituents.


Referring to the embodiments as depicted in FIG. 2 and FIG. 3, it will be appreciated that an elongated dilator assembly 102, an elongated needle assembly 202 and the stop-movement device 300 may be manufactured, or provided by, separately. The apparatus includes, and is not limited to, a stop-movement device 300 configured to be mounted to the elongated needle assembly 202 and the elongated dilator assembly 102; this is done, preferably, after the elongated needle assembly 202, in use, is received, at least in part, inside the elongated dilator assembly 102.


The stop-movement device 300 has a body 301 configured to stop, at least in part, relative movement between the elongated needle assembly 202 and the elongated dilator assembly 102; this is done, preferably, after the stop-movement device 300 is mounted to the elongated needle assembly 202 and the elongated dilator assembly 102.


Referring to the embodiments as depicted in FIG. 2 and FIG. 3, it will be appreciated that the elongated dilator assembly 102, the elongated needle assembly 202 and the stop-movement device 300 may be manufactured, or provided by, a single entity or company. The apparatus includes and is not limited to a synergistic combination of the elongated dilator assembly 102, the elongated needle assembly 202 and the stop-movement device 300. The stop-movement device 300 is configured to be mounted to the elongated needle assembly 202 and the elongated dilator assembly 102; this is done, preferably, after the elongated needle assembly 202, in use, is received, at least in part, inside the elongated dilator assembly 102. The stop-movement device 300 has a body 301 configured to stop, at least in part, relative movement between the elongated needle assembly 202 and the elongated dilator assembly 102; this is done, preferably, after the stop-movement device 300 is mounted to the elongated needle assembly 202 and the elongated dilator assembly 102.


Referring to the embodiment as depicted in FIG. 2, the elongated dilator assembly 102 is configured to be received in a sheath assembly 402. The elongated dilator assembly 102 includes a proximal end portion 103 that extends from the sheath assembly 402. The dilator hub portion 104 extends from the proximal end portion 103. A handle 206 is attached to the proximal end portion of the elongated needle assembly 202.


Referring to the embodiments as depicted in FIG. 2 and FIG. 3, there is depicted a method (steps) for using the stop-movement device 300 with the elongated dilator assembly 102 and the elongated needle assembly 202. The method includes mounting the stop-movement device 300 to the elongated needle assembly 202 and the elongated dilator assembly 102 after the elongated needle assembly 202, in use, is received, at least in part, inside the elongated dilator assembly 102. The method also includes stopping relative movement between the elongated needle assembly 202 and the elongated dilator assembly 102 with a body 301 of the stop-movement device 300 after the stop-movement device 300 is mounted to the elongated needle assembly 202 and the elongated dilator assembly 102.


Referring to the embodiments as depicted in FIG. 2 and FIG. 3, the elongated needle assembly 202 includes (preferably) a shape-memory material configured to be manipulated and/or deformed followed by a return to the original shape that the shape-memory material was set in (prior to manipulation). Shape-memory materials (SMMs) are known and not further described in detail. Shape-memory materials are configured to recover their original shape from a significant and seemingly plastic deformation in response to application of a particular (predetermined) stimulus (force) to the shape-memory material. This is known as the shape memory effect (SME). Superelasticity (in alloys) may be observed once, or after, the shape-memory material is deformed under the presence (an application) of a stimulus force.


Referring to the embodiments as depicted in FIG. 2 and FIG. 3, the elongated dilator assembly 102 and the elongated needle assembly 202 (including the first elongated medical assembly 100 and the second elongated medical assembly 200) are configured to be inserted into a confined space or tortuous space defined by a living body (the patient).


Referring to the embodiments as depicted in FIG. 2 and FIG. 3, the elongated dilator assembly 102 and the elongated needle assembly 202 (including the first elongated medical assembly 100 and the second elongated medical assembly 200) are (preferably) impermeable by a bodily fluid located in the confined space defined by the living body (of the patient).


Referring to the embodiments as depicted in FIG. 2 and FIG. 3, the elongated dilator assembly 102 and the elongated needle assembly 202 (including the first elongated medical assembly 100 and the second elongated medical assembly 200) include (in accordance with a preferred embodiment) biocompatible material properties suitable for sufficient performance (dielectric strength, thermal performance, insulation and corrosion, water and heat resistance) for safe performance to comply with industrial and regulatory safety standards (or compatible for medical usage). Reference is made to the following publication for consideration in the selection of a suitable material: Plastics in Medical Devices: Properties, Requirements, and Applications; 2nd Edition; author. Vinny R. Sastri; hardcover ISBN: 9781455732012; published: 21 Nov. 2013; publisher: Amsterdam [Pays-Bas]: Elsevier/William Andrew, [2014].


Referring to the embodiment as depicted in FIG. 2, the elongated needle assembly 202 includes (preferably) a distal puncture device 204.


Referring to the embodiment as depicted in FIG. 2, the distal puncture device 204 includes (preferably) an energy emitting device. The energy emitting device, for instance, may include a radio frequency puncture device, such as the BAYLIS (TRADEMARK) NRG (REGISTERED TRADEMARK) radio frequency needle manufactured by the BAYLIS MEDICAL COMPANY (headquartered in Canada). For the case as depicted in FIG. 2, an energy generator 900 is electrically connected to the distal puncture device 204 via an electrical connection 902 using connection plugs and/or structures that are known and not described in detail. In accordance with another embodiment (known and not depicted), the elongated needle assembly 202 includes (and is not limited to) an elongated needle having a distal tip section presenting a mechanical cutting portion (for this case, the puncture hole may be formed by physically moving the mechanical cutting portion into the biological feature or wall, etc.).


Referring to the embodiment as depicted in FIG. 3, the body 301 (of the stop-movement device 300) includes (preferably) an elastically deformable material defining a receiving portal 302. The receiving portal 302 is aligned coaxially with a longitudinal axis that extends between opposite end sections (faces) of the body 301. The receiving portal 302 (defined by the body 301) is configured to receive, at least in part, and hold onto a portion of the elongated dilator assembly 102 and a portion of the elongated needle assembly 202. Generally, the stop-movement device 300 is configured to selectively receive, at least in part, and hold onto the elongated dilator assembly 102 and the elongated needle assembly 202, and the stop-movement device 300 is configured to selectively release from the elongated dilator assembly 102 and the elongated needle assembly 202. The body 301 has a resilient material. The definition of resilient material may include an elastically deformable material, an elastically resilient material, a sticky material, a friction fitted material, etc. The stop-movement device 300 may be shaped to be friction fitted, at least in part, to a portion of an outer surface of the elongated needle assembly 202. The stop-movement device 300 may be shaped to be friction fitted, at least in part, to a portion of an outer surface of the elongated dilator assembly 102 (such as, to the outer surface of the dilator hub portion 104 of the elongated dilator assembly 102). Friction fitted may include tight fit, malleable, sticky, etc. The stop-movement device 300 is shaped to fit around, at least in part, a portion of an outer diameter of the elongated needle assembly 202. The stop-movement device 300 is shaped to fit around, at least in part, a portion of an outer diameter of the elongated dilator assembly 102 (or the dilator hub portion 104 of the elongated dilator assembly 102). After (or once) the stop-movement device 300 is installed to the elongated dilator assembly 102 and the elongated needle assembly 202, relative movement between the elongated needle assembly 202 and the elongated dilator assembly 102 is prevented or stopped by the stop-movement device 300. The stop-movement device 300 is configured to stop, at least in part, relative movement between the elongated needle assembly 202 and the elongated dilator assembly 102. This is done so that the distal puncture device 204 of the elongated needle assembly 202 is held stationary and cannot be movable relative to the elongated dilator assembly 102 (that is, the elongated needle assembly 202 is prevented from moving along the interior of the elongated dilator assembly 102). The stop-movement device 300 is configured to selectively lock the position of the elongated needle assembly 202 to the elongated dilator assembly 102 so that the distal puncture device 204 may be secured (preferably, without having to use the two-finger technique). The stop-movement device 300 provides improved safety for the surgeon and/or the patient during a procedure, such as a transseptal procedure associated with puncturing the fossa ovalis, etc. The stop-movement device 300 may be utilized for any type of puncture formation, such as forming a puncture across the interventricular septum, between blood vessels, a transcaval procedure, a reverse Potts Shunt procedure or the Glenn Shunt procedure, etc., and any equivalent thereof.


Referring to the embodiment as depicted in FIG. 3, when the stop-movement device 300 is positioned to lock the elongated needle assembly 202 with the elongated dilator assembly 102, the elongated needle assembly 202 is not able to be moved inside and along the elongated dilator assembly 102. When the stop-movement device 300 is removed from the elongated dilator assembly 102 and the elongated needle assembly 202 (the stop-movement device 300 is released), the elongated needle assembly 202 (and the distal puncture device 204) are movable inside and along the elongated dilator assembly 102. The sheath assembly 402 is movable along the elongated dilator assembly 102. The stop-movement device 300 is configured to selectively fit tightly around, at least in part, the elongated dilator assembly 102 and the elongated needle assembly 202 (but may be selectively released therefrom, as desired). This is done (preferably) in such a way that the elongated dilator assembly 102 and the elongated needle assembly 202 are selectively locked relative to each other. The stop-movement device 300 includes (preferably) a single component for the body 301. It will be appreciated that the stop-movement device 300 may include multiple pieces that are fitted together (snap fitted, click connected, etc.), for the formation of the body 301 (if desired).



FIG. 4 to FIG. 10 depict side views (FIG. 4, FIG. 5, FIG. 6, FIG. 8 and FIG. 10) and perspective side views (FIG. 7 and FIG. 9) of embodiments of a method of utilizing the stop-movement device 300 of FIG. 2.


Referring to the embodiments as depicted in FIG. 4 to FIG. 10, there is depicted a method for a procedure. With reference to FIG. 4, the procedure includes advancing the guidewire 401 into a biological feature 904 (such as the superior vena cava of the heart, etc.). With reference to FIG. 5, the procedure includes advancing the elongated dilator assembly 102 and the sheath assembly 402 over the guidewire 401 into the biological feature 904. The procedure also includes removing the guidewire 401 after the elongated dilator assembly 102 and the sheath assembly 402 are positioned as desired. With reference to FIG. 6, the procedure includes advancing the elongated needle assembly 202 having the distal puncture device 204 proximal to the dilator tip 105 of the elongated dilator assembly 102. With reference to FIG. 6, the procedure includes using the stop-movement device 300 to lock the elongated dilator assembly 102 to the elongated needle assembly 202. Locking may be done by pushing the stop-movement device 300 onto the dilator hub portion 104 and a portion of the elongated dilator assembly 102 (as depicted in FIG. 3, if so desired). With reference to FIG. 8, the procedure includes moving (clocking) the elongated needle assembly 202 and the elongated dilator assembly 102 together (in unison) to a desired position (with help from the stop-movement device 300). The procedure may include moving the elongated needle assembly 202 and the elongated dilator assembly 102 together to a desired location (such as, the fossa ovalis). The procedure may include tenting the desired biological feature with the distal tip of the elongated needle assembly 202, etc., if so desired. With reference to FIG. 9, the procedure includes removing the stop-movement device 300 (thereby releasing the elongated dilator assembly 102 and the elongated needle assembly 202 from each other); in this manner, once released, the elongated needle assembly 202 may be advanced so that energy may be emitted (applied) to make (form) the puncture 905 (it is understood that the elongated needle assembly 202 forms the puncture, not the elongated dilator assembly 102). Releasing the stop-movement device 300 may be done by pulling the stop-movement device 300 off the dilator hub portion 104 and a portion of the elongated needle assembly 202, etc. The procedure may include continuing with the rest of (the remaining steps of) a procedure (such as, the transseptal puncture procedure, etc.).


Referring to the embodiment as depicted in FIG. 4, a guidewire 401 is advanced (maneuvered) along the first movement direction 601, into a biological feature 904 (such as the superior vena cava of the heart) of a patient. It will be appreciated that for FIG. 0.4, FIG. 5, FIG. 6 and FIG. 10, the first movement direction 601 refers to the motion of advancing the puncture device, whereas for FIG. 7, FIG. 9, and FIG. 13, the first movement direction 601 refers to the motion of moving (pushing down or pulling up) the stop-movement device 300.


Referring to the embodiment as depicted in FIG. 5, the sheath assembly 402 and the dilator assembly 102 are advanced over the guidewire assembly 401 (without the elongated needle assembly 202), then the guidewire assembly 401 is removed, and then the elongated needle assembly 202 is advanced along the sheath assembly 402 and the dilator assembly 102 and into the biological feature (such as a wall or the superior vena cava of the heart, etc.).


Referring to the embodiment as depicted in FIG. 6, the elongated needle assembly 202 with the distal puncture device 204 are advanced, along the first movement direction 601, to a position that is about one (1) centimeter proximal to the dilator tip 105 of the elongated dilator assembly 102.


Referring to the embodiment as depicted in FIG. 7, before installing the stop-movement device 300, the elongated dilator assembly 102 and the elongated needle assembly 202 are movable (freely movable) along an axial movement direction 603. The elongated needle assembly 202 may freely move into the end section 112 of the elongated dilator assembly 102, etc. The stop-movement device 300 defines a first interior zone 501 configured to selectively engage with a portion of the elongated dilator assembly 102. The stop-movement device 300 defines a second interior zone 502 configured to selectively engage with a portion of the elongated needle assembly 202. To install the stop-movement device 300 for locking the elongated dilator assembly 102 and the elongated needle assembly 202 together, the stop-movement device 300 is moved along a first movement direction 601 toward the elongated dilator assembly 102 and the elongated needle assembly 202. This is done so that the receiving portal 302 receives the elongated dilator assembly 102 and the elongated needle assembly 202 (into the first interior zone 501 and the second interior zone 502, respectively). Once the stop-movement device 300 is installed, the elongated dilator assembly 102 and the elongated needle assembly 202 cannot move relative to each other along the axial movement direction 603. The stop-movement device 300 also includes a step 384 positioned between the first interior zone 501 and the second interior zone 502. Once the stop-movement device 300 is installed, the step 384 abuts the end section 112 of the elongated dilator assembly 102.


Referring to the embodiment as depicted in FIG. 8, the sheath assembly 402, the elongated dilator assembly 102 and the elongated needle assembly 202 are moved or rotated (clocked from about the three o'clock position to about the 6 o'clock position, while the stop-movement device 300 remains installed). Then, the sheath assembly 402, the elongated dilator assembly 102 and the elongated needle assembly 202 are moved (pulled) down to a biological wall (such as the fossa ovalis of the heart); this is done in such a way that the top of the sheath assembly 402 (or the elongated dilator assembly 102) tents (elastically deforms) the biological wall (such as, the fossa ovalis, etc.).


Referring to the embodiment as depicted in FIG. 9, after the distal sections of the sheath assembly 402, the elongated dilator assembly 102 and the elongated needle assembly 202 are positioned as desired, the stop-movement device 300 is removed from the elongated dilator assembly 102 and the elongated needle assembly 202. This is done so that the elongated dilator assembly 102 and the elongated needle assembly 202 may become movable (freely movable) along the axial movement direction 603. To remove the stop-movement device 300 for unlocking the elongated dilator assembly 102 and the elongated needle assembly 202 from each other, the stop-movement device 300 is moved along the first movement direction 601 away from the elongated dilator assembly 102 and the elongated needle assembly 202 so that the elongated dilator assembly 102 and the elongated needle assembly 202 become removed from the receiving portal 302 (that is, become removed from the first interior zone 501 and the second interior zone 502, respectively). Once the stop-movement device 300 is removed, the elongated dilator assembly 102 and the elongated needle assembly 202 may move relative to each other along the axial movement direction 603. Once the stop-movement device 300 is removed, the step 384 no longer abuts the end section 112 of the elongated dilator assembly 102.


Referring to the embodiment as depicted in FIG. 10, after the stop-movement device 300 is removed from the elongated dilator assembly 102 and the elongated needle assembly 202, the elongated needle assembly 202 may be deployed so that the distal puncture device 204 is utilized for formation of the puncture hole 905. For the case where the distal puncture device 204 includes a mechanical needle, the elongated needle assembly 202 is advanced into the biological feature (such as a biological wall, etc.). For the case where the distal puncture device 204 includes an energy emitting device (such as, a radio frequency emitter, etc., and any equivalent thereof), the energy emitting device is activated to form the puncture hole 905. The remainder of the transseptal puncture procedure may be conducted accordingly.


Referring to the embodiment as depicted in FIG. 3, it will be appreciated that the stop-movement device 300 is configured to accommodate the dimensions of the various types of known puncture devices. The shape of the dilator hub portion 104 may be accommodated.


The stop-movement device 300 may include (preferably) a high-density polyethylene (HDPE). The stop-movement device 300 includes or defines (preferably) the receiving portal 302 (also called a slit) configured to allow the stop-movement device 300 to fit over (at least in part) and locably engage (snap onto) a portion of the elongated dilator assembly 102 and a portion of the elongated needle assembly 202. FIG. 11 to FIG. 14 depict end perspective views (FIG. 11 and FIG. 14), an end view (FIG. 12) and a side perspective view (FIG. 13) of embodiments of the stop-movement device 300 of FIG. 2.


Referring to the embodiments as depicted in FIG. 11 and FIG. 12, the body 301 (of the stop-movement device 300) includes (preferably) a single body member 380. The single body member 380 includes a first end face 381 and a second end face 382. The first end face 381 is configured to be positioned over (at least in part) the elongated dilator assembly 102 (as depicted in FIG. 3). The second end face 382 is configured to be positioned over (at least in part) the elongated needle assembly 202 (as depicted in FIG. 3). The single body member 380 also includes a step 384 positioned between the first end face 381 and the second end face 382. The single body member 380 also includes a first inner wall surface 391 configured to (frictionally engage) contact the outer surface of the elongated dilator assembly 102 (as depicted in FIG. 3). The single body member 380 also includes a second inner wall surface 392 configured to (frictionally engage) contact the outer surface of the elongated needle assembly 202 (as depicted in FIG. 3). The receiving portal 302 (also called an axial groove) is aligned coaxially with a longitudinal axis. The receiving portal 302 extends between opposite end sections of the single body member 380 (or the body 301) or the opposite end faces of the single body member 380 (or the body 301), etc.


Referring to the embodiments as depicted in FIG. 13 and FIG. 14, the stop-movement device 300 includes a first body 311 and a second body 312. The second body 312 is configured to be selectively mated and connected (snap fitted together) to the first body 311. The first body 311 and the second body 312 may be separately friction fitted (engaged) to portions of the elongated dilator assembly 102 and the elongated needle assembly 202. The first body 311 is movable along a first movement direction 601 to meet up, and selectively mate (interface) with, the second body 312. Alternatively, the second body 312 is movable along a second movement direction 602 to meet up, and selectively mate (interface) with, the first body 311. The first body 311 defines a first body cavity 321 configured to contact a portion of the elongated needle assembly 202.


The first body 311 defines a first body groove 322 configured to contact a portion of the elongated dilator assembly 102. The first body cavity 321 and the first body groove 322 are in fluid communication with each other. A first step 341 is located between the first body cavity 321 and the first body groove 322. The second body 312 defines a second body cavity 331 configured to contact a portion of the elongated needle assembly 202. The second body 312 defines a second body groove 332 configured to contact a portion of the elongated dilator assembly 102. The second body cavity 331 and the second body groove 332 are in fluid communication with each other. A second step 342 is located between the first body cavity 321 and the first body groove 322. The first body cavity 321 and the second body cavity 331 are configured to face each other after the second body 312 is selectively mated and connected to the first body 311. The first body groove 322 and the second body groove 332 are configured to face each other after the second body 312 is selectively mated and connected to the first body 311. The first step 341 and the second step 342 are coplanar after the second body 312 is selectively mated and connected to the first body 311. The first body 311 and the second body 312 cooperate to define a first entrance 351 leading into the first body cavity 321 and the second body cavity 331 (after the second body 312 is selectively mated and connected to the first body 311). The first body 311 and the second body 312 cooperate (once mated together) to define a second entrance 352 leading into the second body groove 332 and the first body groove 322 (after the second body 312 is selectively mated and connected to the first body 311). The first body 311 provides a first connection protrusion 361. The second body 312 provides a second connection protrusion 362. The first body 311 provides a first connection groove 371. The second body 312 provides a second connection groove 372. The first connection protrusion 361 is configured to be securely received into the second connection groove 372. The second connection protrusion 362 is configured to be securely received into the first connection groove 371.


The following is offered as further description of the embodiments, in which any one or more of any technical feature (described in the detailed description, the summary and the claims) may be combinable with any other one or more of any technical feature (described in the detailed description, the summary and the claims). It is understood that each claim in the claims section is an open ended claim unless stated otherwise. Unless otherwise specified, relational terms used in these specifications should be construed to include certain tolerances that the person skilled in the art would recognize as providing equivalent functionality. By way of example, the term perpendicular is not necessarily limited to 90.0 degrees, and may include a variation thereof that the person skilled in the art would recognize as providing equivalent functionality for the purposes described for the relevant member or element. Terms such as “about” and “substantially”, in the context of configuration, relate generally to disposition, location, or configuration that are either exact or sufficiently close to the location, disposition, or configuration of the relevant element to preserve operability of the element within the disclosure which does not materially modify the disclosure. Similarly, unless specifically made clear from its context, numerical values should be construed to include certain tolerances that the person skilled in the art would recognize as having negligible importance as they do not materially change the operability of the disclosure. It will be appreciated that the description and/or drawings identify and describe embodiments of the apparatus (either explicitly or inherently). The apparatus may include any suitable combination and/or permutation of the technical features as identified in the detailed description, as may be required and/or desired to suit a particular technical purpose and/or technical function. It will be appreciated that, where possible and suitable, any one or more of the technical features of the apparatus may be combined with any other one or more of the technical features of the apparatus (in any combination and/or permutation). It will be appreciated that persons skilled in the art would know that the technical features of each embodiment may be deployed (where possible) in other embodiments even if not expressly stated as such above. It will be appreciated that persons skilled in the art would know that other options may be possible for the configuration of the components of the apparatus to adjust to manufacturing requirements and still remain within the scope as described in at least one or more of the claims. This written description provides embodiments, including the best mode, and also enables the person skilled in the art to make and use the embodiments. The patentable scope may be defined by the claims. The written description and/or drawings may help to understand the scope of the claims. It is believed that all the crucial aspects of the disclosed subject matter have been provided in this document. It is understood, for this document, that the word “includes” is equivalent to the word “comprising” in that both words are used to signify an open-ended listing of assemblies, components, parts, etc. The term “comprising”, which is synonymous with the terms “including,” “containing,” or “characterized by,” is inclusive or open-ended and does not exclude additional, unrecited elements or method steps. Comprising (comprised of) is an “open” phrase and allows coverage of technologies that employ additional, unrecited elements. When used in a claim, the word “comprising” is the transitory verb (transitional term) that separates the preamble of the claim from the technical features of the disclosure. The foregoing has outlined the non-limiting embodiments (examples). The description is made for particular non-limiting embodiments (examples). It is understood that the non-limiting embodiments are merely illustrative as examples.

Claims
  • 1. An apparatus, comprising: an elongated dilator assembly defining a lumen; andan elongated needle assembly configured to be receivable and movable within the lumen; anda stop-movement device having a generally cylindrical body defining a longitudinal interior passage including, a first inner wall surface having a first interior dimension and configured to engage a portion of the elongated dilator assembly,a second inner wall surface adjacent the first inner wall surface, the second inner wall surface having a second interior dimension and configured to engage a portion of the elongated needle assembly, the first interior dimension being greater than the second interior dimension, anda step disposed in the interior passage at an intersection of the first and second inner wall surfaces and configured to be mounted to the elongated needle assembly and the elongated dilator assembly after the elongated needle assembly, in use, is received, at least in part, inside the lumen of the elongated dilator assembly; andwherein the step of the stop-movement device is configured to contact a proximal end of the elongated dilator assembly so as to inhibit relative movement between the elongated needle assembly and the elongated dilator assembly in a distal direction.
  • 2. The apparatus of claim 1, wherein: the elongated dilator assembly is configured to be received in a sheath assembly.
  • 3. The apparatus of claim 1, wherein: the stop-movement device includes an elastically deformable material.
  • 4. The apparatus of claim 1, wherein: the stop-movement device is configured to selectively receive, at least in part, and hold onto the elongated dilator assembly and the elongated needle assembly; andthe stop-movement device is configured to selectively release from the elongated dilator assembly and the elongated needle assembly.
  • 5. The apparatus of claim 1, wherein: the stop-movement device is configured to be friction fitted, at least in part, to a portion of an outer surface of the elongated needle assembly.
  • 6. The apparatus of claim 1, wherein: the stop-movement device is configured to be friction fitted, at least in part, to a portion of an outer surface of the elongated dilator assembly.
  • 7. The apparatus of claim 1, wherein: the second inner wall surface is shaped to fit around, at least in part, a portion of an outer diameter of the elongated needle assembly; andthe first inner wall surface is shaped to fit around, at least in part, a portion of an outer diameter of the elongated dilator assembly.
  • 8. The apparatus of claim 1, wherein: the elongated needle assembly is not able to be moved inside and along the elongated dilator assembly after the stop-movement device is positioned to lock the elongated needle assembly with the elongated dilator assembly; andthe elongated needle assembly is movable inside, and along, the elongated dilator assembly after the stop-movement device is removed from the elongated dilator assembly and the elongated needle assembly.
  • 9. The apparatus of claim 1, wherein: the stop-movement device is configured to selectively fit tightly around, at least in part, the elongated dilator assembly and the elongated needle assembly in such a way that the stop-movement device, in use, selectively locks the elongated dilator assembly and the elongated needle assembly to each other.
  • 10. The apparatus of claim 1, wherein: the stop-movement device is configured to fit over, at least in part, and lockably engage, at least in part, the elongated dilator assembly and the elongated needle assembly.
  • 11. The apparatus of claim 1, wherein: the body of the stop-movement device includes a single body member including the first inner wall surface and is configured to frictionally engage a portion of the elongated dilator assembly; and the single body member also includes the second inner wall surface and is configured to frictionally engage a portion of the elongated needle assembly.
  • 12. The apparatus of claim 1, wherein: the body of the stop-movement device includes: a first body portion defining a first body cavity configured to contact a portion of the elongated needle assembly, a first body groove configured to contact a portion of the elongated dilator assembly and a first step located between the first body cavity and the first body groove; and a second body portion configured to be selectively coupled to the first body portion; wherein the first body cavity and the first body groove are in fluid communication with each other.
  • 13. The apparatus of claim 12, wherein: the second body portion defines a second body cavity configured to contact a portion of the elongated needle assembly;the second body portion defines a second body groove configured to contact a portion of the elongated dilator assembly;the second body cavity and the second body groove are in fluid communication with each other; andthe second body portion includes a second step located between the first body cavity and the first body groove.
  • 14. The apparatus of claim 13, wherein: the first body cavity and the second body cavity are configured to face each other after the second body portion is selectively mated and connected to the first body portion; andthe first body groove and the second body groove are configured to face each other after the second body portion is selectively mated and connected to the first body portion; andthe first step and the second step are coplanar after the second body portion is selectively mated and connected to the first body portion.
  • 15. The apparatus of claim 14, wherein: the first body portion and the second body portion cooperate to define:a first entrance leading into the first body cavity and the second body cavity after the second body portion is selectively mated and connected to the first body portion; anda second entrance leading into the second body groove and the first body groove after the second body portion is selectively mated and connected to the first body portion.
  • 16. The apparatus of claim 15, wherein: the first body portion provides a first connection protrusion;the second body portion provides a second connection protrusion;the first body portion provides a first connection groove;the second body portion provides a second connection groove,the first connection protrusion is configured to be securely received into the second connection groove; andthe second connection protrusion is configured to be securely received into the first connection groove.
US Referenced Citations (317)
Number Name Date Kind
175254 Oberly Mar 1876 A
827626 Gillet Jul 1906 A
848711 Weaver Apr 1907 A
1072954 Junn Sep 1913 A
1279654 Charlesworth Sep 1918 A
1918094 Geekas Jul 1933 A
1996986 Weinberg Apr 1935 A
2021989 De Master Nov 1935 A
2146636 Lipchow Feb 1939 A
3429574 Williams Feb 1969 A
3448739 Stark et al. Jun 1969 A
3575415 Fulp et al. Apr 1971 A
3595239 Petersen Jul 1971 A
4129129 Amrine Dec 1978 A
4244362 Anderson Jan 1981 A
4401124 Guess et al. Aug 1983 A
4639252 Kelly et al. Jan 1987 A
4641649 Walinsky et al. Feb 1987 A
4669467 Willett et al. Jun 1987 A
4682596 Bales et al. Jul 1987 A
4790311 Ruiz Dec 1988 A
4790809 Kuntz Dec 1988 A
4793350 Mar et al. Dec 1988 A
4807620 Strul et al. Feb 1989 A
4832048 Cohen May 1989 A
4840622 Hardy Jun 1989 A
4863441 Lindsay et al. Sep 1989 A
4884567 Elliott et al. Dec 1989 A
4892104 Ito et al. Jan 1990 A
4896671 Cunningham et al. Jan 1990 A
4928693 Goodin et al. May 1990 A
4936281 Stasz Jun 1990 A
4960410 Pinchuk Oct 1990 A
4977897 Hurwitz Dec 1990 A
4998933 Eggers et al. Mar 1991 A
5006119 Acker et al. Apr 1991 A
5019076 Yamanashi et al. May 1991 A
5047026 Rydell Sep 1991 A
5081997 Bosley et al. Jan 1992 A
5098431 Rydell Mar 1992 A
5112048 Kienle May 1992 A
5149324 Clawson Sep 1992 A
5154724 Andrews Oct 1992 A
5201756 Horzewski et al. Apr 1993 A
5209741 Spaeth May 1993 A
5211183 Wilson May 1993 A
5221256 Mahurkar Jun 1993 A
5230349 Langberg Jul 1993 A
5281216 Klicek Jan 1994 A
5300068 Rosar et al. Apr 1994 A
5300069 Hunsberger et al. Apr 1994 A
5314418 Takano et al. May 1994 A
5318525 West et al. Jun 1994 A
5327905 Avitall Jul 1994 A
5364393 Auth et al. Nov 1994 A
5372596 Klicek et al. Dec 1994 A
5380304 Parker Jan 1995 A
5397304 Truckai Mar 1995 A
5403338 Milo Apr 1995 A
5423809 Klicek Jun 1995 A
5425382 Golden et al. Jun 1995 A
5490859 Mische et al. Feb 1996 A
5497774 Swartz et al. Mar 1996 A
5507751 Goode et al. Apr 1996 A
5509411 Littmann et al. Apr 1996 A
5540681 Strul et al. Jul 1996 A
5545200 West et al. Aug 1996 A
5555618 Winkler Sep 1996 A
5571088 Lennox et al. Nov 1996 A
5575766 Swartz et al. Nov 1996 A
5575772 Lennox Nov 1996 A
5599347 Hart et al. Feb 1997 A
5605162 Mirzaee et al. Feb 1997 A
5617878 Taheri Apr 1997 A
5622169 Golden et al. Apr 1997 A
5624430 Eton et al. Apr 1997 A
5626607 Malecki et al. Apr 1997 A
5667488 Lundquist et al. Sep 1997 A
5673695 McGee et al. Oct 1997 A
5674208 Berg et al. Oct 1997 A
5683366 Eggers et al. Nov 1997 A
5720744 Eggleston et al. Feb 1998 A
5741249 Moss et al. Apr 1998 A
5766135 Terwilliger Jun 1998 A
5779688 Imran et al. Jul 1998 A
5810764 Eggers et al. Sep 1998 A
5814028 Swartz et al. Sep 1998 A
5830214 Flom et al. Nov 1998 A
5836875 Webster, Jr. Nov 1998 A
5849011 Jones et al. Dec 1998 A
5851210 Torossian Dec 1998 A
5885227 Finlayson Mar 1999 A
5888201 Stinson et al. Mar 1999 A
5893848 Negus et al. Apr 1999 A
5893885 Webster, Jr. Apr 1999 A
5904679 Clayman May 1999 A
5916210 Winston Jun 1999 A
5921957 Killion et al. Jul 1999 A
5931818 Werp et al. Aug 1999 A
5944023 Johnson et al. Aug 1999 A
5951482 Winston et al. Sep 1999 A
5957842 Littmann et al. Sep 1999 A
5964757 Ponzi Oct 1999 A
5967976 Larsen et al. Oct 1999 A
5989276 Houser et al. Nov 1999 A
6007555 Devine Dec 1999 A
6009877 Edwards Jan 2000 A
6013072 Winston et al. Jan 2000 A
6017340 Cassidy et al. Jan 2000 A
6018676 Davis et al. Jan 2000 A
6030380 Auth et al. Feb 2000 A
6032674 Eggers et al. Mar 2000 A
6048349 Winston et al. Apr 2000 A
6053870 Fulton, III Apr 2000 A
6053904 Scribner et al. Apr 2000 A
6056747 Saadat et al. May 2000 A
6063093 Winston et al. May 2000 A
6093185 Ellis et al. Jul 2000 A
6106515 Winston et al. Aug 2000 A
6106520 Laufer et al. Aug 2000 A
6117131 Taylor Sep 2000 A
6142992 Cheng et al. Nov 2000 A
6146380 Racz et al. Nov 2000 A
6155264 Ressemann et al. Dec 2000 A
6156031 Aita et al. Dec 2000 A
6171305 Sherman Jan 2001 B1
6179824 Eggers et al. Jan 2001 B1
6193676 Winston et al. Feb 2001 B1
6193715 Wrublewski et al. Feb 2001 B1
6210408 Chandrasekaran et al. Apr 2001 B1
6217575 Devore et al. Apr 2001 B1
6221061 Engelson et al. Apr 2001 B1
6228076 Winston et al. May 2001 B1
6245054 Fuimaono et al. Jun 2001 B1
6267758 Daw et al. Jul 2001 B1
6283983 Makower et al. Sep 2001 B1
6292678 Hall et al. Sep 2001 B1
6293945 Parins et al. Sep 2001 B1
6296615 Brockway et al. Oct 2001 B1
6296636 Cheng et al. Oct 2001 B1
6302898 Edwards et al. Oct 2001 B1
6304769 Arenson et al. Oct 2001 B1
6315777 Comben Nov 2001 B1
6328699 Eigler et al. Dec 2001 B1
6360128 Kordis et al. Mar 2002 B2
6364877 Goble et al. Apr 2002 B1
6385472 Hall et al. May 2002 B1
6394976 Winston et al. May 2002 B1
6395002 Ellman et al. May 2002 B1
6419674 Bowser et al. Jul 2002 B1
6428551 Hall et al. Aug 2002 B1
6450989 Dubrul et al. Sep 2002 B2
6475214 Moaddeb Nov 2002 B1
6485485 Winston et al. Nov 2002 B1
6508754 Liprie et al. Jan 2003 B1
6524303 Garibaldi Feb 2003 B1
6530923 Dubrul et al. Mar 2003 B1
6554827 Chandrasekaran et al. Apr 2003 B2
6562031 Chandrasekaran et al. May 2003 B2
6562049 Norlander et al. May 2003 B1
6565562 Shah et al. May 2003 B1
6607529 Jones et al. Aug 2003 B1
6632222 Edwards et al. Oct 2003 B1
6639999 Cookingham et al. Oct 2003 B1
6650923 Lesh et al. Nov 2003 B1
6651672 Roth Nov 2003 B2
6662034 Segner et al. Dec 2003 B2
6663621 Winston et al. Dec 2003 B1
6702811 Stewart et al. Mar 2004 B2
6709444 Makower Mar 2004 B1
6723052 Mills Apr 2004 B2
6733511 Hall et al. May 2004 B2
6740103 Hall et al. May 2004 B2
6752800 Winston et al. Jun 2004 B1
6755816 Ritter et al. Jun 2004 B2
6811544 Schaer Nov 2004 B2
6814733 Schwartz et al. Nov 2004 B2
6820614 Bonutti Nov 2004 B2
6834201 Gillies et al. Dec 2004 B2
6842639 Winston et al. Jan 2005 B1
6852109 Winston et al. Feb 2005 B2
6855143 Davison et al. Feb 2005 B2
6860856 Ward et al. Mar 2005 B2
6869431 Maguire et al. Mar 2005 B2
6911026 Hall et al. Jun 2005 B1
6951554 Johansen et al. Oct 2005 B2
6951555 Suresh et al. Oct 2005 B1
6955675 Jain Oct 2005 B2
6970732 Winston et al. Nov 2005 B2
6980843 Eng et al. Dec 2005 B2
7029470 Francischelli et al. Apr 2006 B2
7056294 Khairkhahan et al. Jun 2006 B2
7083566 Tornes et al. Aug 2006 B2
7112197 Hartley et al. Sep 2006 B2
7335197 Sage et al. Feb 2008 B2
7618430 Scheib Nov 2009 B2
7651492 Wham Jan 2010 B2
7666203 Chanduszko et al. Feb 2010 B2
7678081 Whiting et al. Mar 2010 B2
7682360 Guerra Mar 2010 B2
7828796 Wong et al. Nov 2010 B2
7900928 Held et al. Mar 2011 B2
8192425 Mirza et al. Jun 2012 B2
8257323 Joseph et al. Sep 2012 B2
8388549 Paul et al. Mar 2013 B2
8500697 Kurth et al. Aug 2013 B2
11339579 Stearns May 2022 B1
20010012934 Chandrasekaran et al. Aug 2001 A1
20010021867 Kordis et al. Sep 2001 A1
20020019644 Hastings et al. Feb 2002 A1
20020022781 McLntire et al. Feb 2002 A1
20020022836 Goble et al. Feb 2002 A1
20020035361 Houser et al. Mar 2002 A1
20020087153 Roschak et al. Jul 2002 A1
20020087156 Maguire et al. Jul 2002 A1
20020111618 Stewart et al. Aug 2002 A1
20020123749 Jain Sep 2002 A1
20020147485 Mamo et al. Oct 2002 A1
20020169377 Khairkhahan et al. Nov 2002 A1
20020188302 Berg et al. Dec 2002 A1
20020198521 Maguire Dec 2002 A1
20030032929 McGuckin Feb 2003 A1
20030040742 Underwood et al. Feb 2003 A1
20030144658 Schwartz et al. Jul 2003 A1
20030158480 Tornes et al. Aug 2003 A1
20030163153 Scheib Aug 2003 A1
20030225392 McMichael et al. Dec 2003 A1
20040015162 McGaffigan Jan 2004 A1
20040024396 Eggers Feb 2004 A1
20040030328 Eggers et al. Feb 2004 A1
20040044350 Martin et al. Mar 2004 A1
20040073243 Sepetka et al. Apr 2004 A1
20040077948 Violante et al. Apr 2004 A1
20040116851 Johansen et al. Jun 2004 A1
20040127963 Uchida et al. Jul 2004 A1
20040133113 Krishnan Jul 2004 A1
20040133130 Ferry et al. Jul 2004 A1
20040143256 Bednarek Jul 2004 A1
20040147950 Mueller et al. Jul 2004 A1
20040181213 Gondo Sep 2004 A1
20040230188 Cioanta et al. Nov 2004 A1
20050004585 Hall et al. Jan 2005 A1
20050010208 Winston et al. Jan 2005 A1
20050049628 Schweikert et al. Mar 2005 A1
20050059966 McClurken et al. Mar 2005 A1
20050065507 Hartley et al. Mar 2005 A1
20050085806 Auge et al. Apr 2005 A1
20050096529 Cooper et al. May 2005 A1
20050101984 Chanduszko et al. May 2005 A1
20050119556 Gillies et al. Jun 2005 A1
20050137527 Kunin Jun 2005 A1
20050149012 Penny et al. Jul 2005 A1
20050203504 Wham et al. Sep 2005 A1
20050203507 Truckai et al. Sep 2005 A1
20050261607 Johansen et al. Nov 2005 A1
20050288631 Lewis et al. Dec 2005 A1
20060041253 Newton et al. Feb 2006 A1
20060074398 Whiting et al. Apr 2006 A1
20060079769 Whiting et al. Apr 2006 A1
20060079787 Whiting et al. Apr 2006 A1
20060079884 Manzo et al. Apr 2006 A1
20060085054 Zikorus et al. Apr 2006 A1
20060089638 Carmel et al. Apr 2006 A1
20060106375 Werneth et al. May 2006 A1
20060135962 Kick et al. Jun 2006 A1
20060142756 Davies et al. Jun 2006 A1
20060189972 Grossman Aug 2006 A1
20060241586 Wilk Oct 2006 A1
20060247672 Vidlund et al. Nov 2006 A1
20060264927 Ryan Nov 2006 A1
20060276710 Krishnan Dec 2006 A1
20070060879 Weitzner et al. Mar 2007 A1
20070066975 Wong et al. Mar 2007 A1
20070118099 Trout, III May 2007 A1
20070123964 Davies et al. May 2007 A1
20070167775 Kochavi et al. Jul 2007 A1
20070208256 Marilla Sep 2007 A1
20070225681 House Sep 2007 A1
20070270791 Wang et al. Nov 2007 A1
20080039865 Shaher et al. Feb 2008 A1
20080042360 Veikley Feb 2008 A1
20080086120 Mirza et al. Apr 2008 A1
20080097213 Carlson et al. Apr 2008 A1
20080108987 Bruszewski et al. May 2008 A1
20080146918 Magnin et al. Jun 2008 A1
20080171934 Greenan et al. Jul 2008 A1
20080208121 Youssef et al. Aug 2008 A1
20080262431 Anderson Oct 2008 A1
20080275439 Francischelli et al. Nov 2008 A1
20090105742 Kurth et al. Apr 2009 A1
20090138009 Viswanathan et al. May 2009 A1
20090163850 Betts et al. Jun 2009 A1
20090177114 Chin et al. Jul 2009 A1
20090264977 Bruszewski et al. Oct 2009 A1
20100087789 Leeflang et al. Apr 2010 A1
20100125282 Machek et al. May 2010 A1
20100168684 Ryan Jul 2010 A1
20100179632 Bruszewski et al. Jul 2010 A1
20100191142 Paul et al. Jul 2010 A1
20100194047 Sauerwine Aug 2010 A1
20110046619 Ducharme Feb 2011 A1
20110152716 Chudzik et al. Jun 2011 A1
20110160592 Mitchell Jun 2011 A1
20110190763 Urban et al. Aug 2011 A1
20120232546 Mirza et al. Sep 2012 A1
20120265055 Melsheimer et al. Oct 2012 A1
20120330156 Brown et al. Dec 2012 A1
20130184551 Paganelli et al. Jul 2013 A1
20130184735 Fischell et al. Jul 2013 A1
20130282084 Mathur et al. Oct 2013 A1
20140206987 Urbanski et al. Jul 2014 A1
20140296769 Hyde et al. Oct 2014 A1
20150272618 Fung Oct 2015 A1
20160220741 Garrison et al. Aug 2016 A1
20190021763 Zhou et al. Jan 2019 A1
20190247035 Gittard et al. Aug 2019 A1
20210162177 Weise et al. Jun 2021 A1
Related Publications (1)
Number Date Country
20210393925 A1 Dec 2021 US
Provisional Applications (1)
Number Date Country
63040037 Jun 2020 US